Expanding Footprint Market expansion is underway with the launch of Eurax Cream and added dermatology sales representatives, signaling opportunities to cross-sell additional branded and generic dermatology products and to pursue international out-licensing or portfolio in-licensing deals.

Product Portfolio Currently offering seven branded and two generic dermatology products, providing multiple entry points for physician education, payer strategies, and bundle offerings that can drive higher prescription rates.

Revenue Momentum Recent quarterly results show revenue beats and modest EPS loss improvement, suggesting a trajectory toward stronger sales performance with scalable marketing initiatives and expanded field force.

Sales Force Growth Headcount added to the sales team in Q2 and ongoing commercial expansion indicate readiness to scale physician outreach, targeting dermatology clinics and specialty accounts to accelerate product adoption.

Strategic Position Publicly traded with a focused dermatology portfolio and active conference presence, presenting opportunities to partner on co-marketing, payer negotiations, and strategic collaborations to enhance market access.